<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial

dc.contributor.authorDemilade A. Adedinsewo
dc.contributor.authorAndrea Carolina Morales-Lara
dc.contributor.authorBosede B. Afolabi
dc.contributor.authorOyewole A. Kushimo
dc.contributor.authorAmam C. Mbakwem
dc.contributor.authorKehinde F. Ibiyemi
dc.contributor.authorJames Ayodele Ogunmodede
dc.contributor.authorHadijat Olaide Raji
dc.contributor.authorSadiq H. Ringim
dc.contributor.authorAbdullahi A. Habib
dc.contributor.authorSabiu M. Hamza
dc.contributor.authorOkechukwu S. Ogah
dc.contributor.authorGbolahan Obajimi
dc.contributor.authorOlugbenga Oluseun Saanu
dc.contributor.authorOlusoji E. Jagun
dc.contributor.authorFrancisca O. Inofomoh
dc.contributor.authorTemitope Adeolu
dc.contributor.authorKamilu M. Karaye
dc.contributor.authorSule A. Gaya
dc.contributor.authorIsiaka Alfa
dc.contributor.authorCynthia Yohanna
dc.contributor.authorK. L. Venkatachalam
dc.contributor.authorJennifer Dugan
dc.contributor.authorXiaoxi Yao
dc.contributor.authorHanna J. Sledge
dc.contributor.authorPatrick W. Johnson
dc.contributor.authorMikolaj A. Wieczorek
dc.contributor.authorZachi I. Attia
dc.contributor.authorSabrina D. Phillips
dc.contributor.authorMohamad H. Yamani
dc.contributor.authorYvonne Butler Tobah
dc.contributor.authorCarl H. Rose
dc.contributor.authorEmily E. Sharpe
dc.contributor.authorFrancisco Lopez-Jimenez
dc.contributor.authorPaul A. Friedman
dc.contributor.authorPeter A. Noseworthy
dc.contributor.authorRickey E. Carter
dc.contributor.authoron behalf of the SPEC-AI Nigeria Investigatorshttp://orcid.org/0000-0002-8629-2029AdedinsewoDemilade A.adedinsewo.demilade@mayo.edu1Morales-LaraAndrea Carolina1http://orcid.org/0000-0002-7511-7567AfolabiBosede B.2http://orcid.org/0000-0002-0760-8014KushimoOyewole A.3MbakwemAmam C.3http://orcid.org/0000-0002-0125-7276IbiyemiKehinde F.4OgunmodedeJames Ayodele5http://orcid.org/0000-0003-4859-5405RajiHadijat Olaide4http://orcid.org/0000-0002-5595-195XRingimSadiq H.6HabibAbdullahi A.7http://orcid.org/0000-0001-5780-6070HamzaSabiu M.6OgahOkechukwu S.8ObajimiGbolahan9SaanuOlugbenga Oluseun9JagunOlusoji E.10http://orcid.org/0000-0003-1851-8724InofomohFrancisca O.11AdeoluTemitope11http://orcid.org/0000-0001-7992-2398KarayeKamilu M.12GayaSule A.13AlfaIsiaka12YohannaCynthia14VenkatachalamK. L.1DuganJennifer15http://orcid.org/0000-0001-9906-7106YaoXiaoxi1516SledgeHanna J.17JohnsonPatrick W.17WieczorekMikolaj A.17http://orcid.org/0000-0002-9706-7900AttiaZachi I.15PhillipsSabrina D.1YamaniMohamad H.1http://orcid.org/0000-0002-0665-1045TobahYvonne Butler18RoseCarl H.18http://orcid.org/0000-0003-4232-0718SharpeEmily E.19Lopez-JimenezFrancisco15http://orcid.org/0000-0001-5052-2948FriedmanPaul A.15http://orcid.org/0000-0002-4308-0456NoseworthyPeter A.15CarterRickey E.17
dc.date.accessioned2026-11-18T07:10:29Z
dc.date.issued2024
dc.descriptionOfficial PMC article XML states CC BY-NC-ND 4.0; verbatim non-commercial redistribution is permitted, with derivative/commercial restrictions noted. [Rights override: NC/ND licence; DARE commercial-eligibility policy requires metadata-only.] Rights classification: METADATA_ONLY. Licence verified from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485252/ (checked 2026-11-18). Source: https://ror.org/05rk03822grid.411782.90000 0004 1803 1817Department of Obstetrics and Gynaecology, College of Medicine and Centre for Clinical Trials, Research and Implementation Science, University of Lagos, Lagos, Nigeria; https://ror.org/00gkd5869grid.411283.d0000 0000 8668 7085Cardiology Unit, Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria; https://ror.org/045vatr18grid.412975.c0000 0000 8878 5287Department of Obstetrics & Gynaecology, University of Ilorin Teaching Hospital, Ilorin, Nigeria; https://ror.org/032kdwk38grid.412974.d0000 0001 0625 9425Department of Medicine, University of Ilorin, Ilorin, Nigeria ORCID: 0000-0002-8629-2029; 0000-0002-7511-7567; 0000-0002-0760-8014; 0000-0002-0125-7276; 0000-0003-4859-5405; 0000-0002-5595-195X; 0000-0001-5780-6070; 0000-0003-1851-8724; 0000-0001-7992-2398; 0000-0001-9906-7106; 0000-0002-9706-7900; 0000-0002-0665-1045; 0000-0003-4232-0718; 0000-0001-5052-2948; 0000-0002-4308-0456 African relevance: Sector: Healthcare. Pragmatic RCT of AI-guided cardiomyopathy screening in Nigerian pregnant and postpartum women, with multiple Nigerian universities and teaching hospitals. Official PMC article XML states CC BY-NC-ND 4.0; verbatim non-commercial redistribution is permitted, with derivative/commercial restrictions noted. [Rights override: NC/ND licence; DARE commercial-eligibility policy requires metadata-only.]
dc.description.abstractNigeria has the highest reported incidence of peripartum cardiomyopathy worldwide. This open-label, pragmatic clinical trial randomized pregnant and postpartum women to usual care or artificial intelligence (AI)-guided screening to assess its impact on the diagnosis left ventricular systolic dysfunction (LVSD) in the perinatal period. The study intervention included digital stethoscope recordings with point of-care AI predictions and a 12-lead electrocardiogram with asynchronous AI predictions for LVSD. The primary end point was identification of LVSD during the study period. In the intervention arm, the primary end point was defined as the number of identified participants with LVSD as determined by a positive AI screen, confirmed by echocardiography. In the control arm, this was the number of participants with clinical recognition and documentation of LVSD on echocardiography in keeping with current standard of care. Participants in the intervention arm had a confirmatory echocardiogram at baseline for AI model validation. A total of 1,232 (616 in each arm) participants were randomized and 1,195 participants (587 intervention arm and 608 control arm) completed the baseline visit at 6 hospitals in Nigeria between August 2022 and September 2023 with follow-up through May 2024. Using the AI-enabled digital stethoscope, the primary study end point was met with detection of 24 out of 587 (4.1%) versus 12 out of 608 (2.0%) patients with LVSD (intervention versus control odds ratio 2.12, 95% CI 1.05–4.27; P = 0.032). With the 12-lead AI-electrocardiogram model, the primary end point was detected in 20 out of 587 (3.4%) versus 12 out of 608 (2.0%) patients (odds ratio 1.75, 95% CI 0.85–3.62; P = 0.125). A similar direction of effect was observed in prespecified subgroup analy
dc.identifier.doi10.1038/s41591-024-03243-9
dc.identifier.urihttps://doi.org/10.1038/s41591-024-03243-9
dc.identifier.urihttps://library.dare.co.zw/handle/123456789/5094
dc.language.isoen
dc.publisherNature Medicine
dc.rightsCC BY-NC-ND 4.0. Licence evidence: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485252/. Official PMC article XML states CC BY-NC-ND 4.0; verbatim non-commercial redistribution is permitted, with derivative/commercial restrictions noted. [Rights override: NC/ND licence; DARE commercial-eligibility policy requires metadata-only.]
dc.rights.holderNamed authors
dc.rights.licenseCC BY-NC-ND 4.0
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourcehttps://ror.org/05rk03822grid.411782.90000 0004 1803 1817Department of Obstetrics and Gynaecology, College of Medicine and Centre for Clinical Trials, Research and Implementation Science, University of Lagos, Lagos, Nigeria; https://ror.org/00gkd5869grid.411283.d0000 0000 8668 7085Cardiology Unit, Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria; https://ror.org/045vatr18grid.412975.c0000 0000 8878 5287Department of Obstetrics & Gynaecology, University of Ilorin Teaching Hospital, Ilorin, Nigeria; https://ror.org/032kdwk38grid.412974.d0000 0001 0625 9425Department of Medicine, University of Ilorin, Ilorin, Nigeria
dc.source.urihttps://doi.org/10.1038/s41591-024-03243-9
dc.subjectHealthcare
dc.subjectPopulation screening
dc.subjectOutcomes research
dc.subjectCardiomyopathies
dc.subjectEpidemiology
dc.subjectNature Medicine
dc.titleArtificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial
dc.typejournal article

Files